Sartorius has launched a new genetically engineered CHO host cell line designed to improve productivity and efficiency.

Production of recombinant monoclonal antibodies (mAbs) for therapeutic use is a multibillion dollar industry. At present, mammalian cell lines are the workhorses of the biotechnology industry, due to ...

In the pursuit of faster and more reliable recombinant protein production, transient transfection has emerged as a cornerstone of early biopharmaceutical development. Compared to stable transfection, ...